Division of Urology, Department of Surgical Oncology Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Int J Urol. 2010 Aug;17(8):727-32. doi: 10.1111/j.1442-2042.2010.02570.x. Epub 2010 Jun 9.
Obesity has been proposed as a risk factor for reduced disease-specific survival, increased positive surgical margin (PSM) and biochemical recurrence (BCR) after radical prostatectomy (RP) in patients with prostate cancer. The aim of this study was to clarify the relationship between obesity and surgical outcomes in patients undergoing RP.
Medical records of 491 patients who underwent RP from 2004 to 2007 were retrieved from our institutional database. Patients were divided into three groups based on their body mass index (BMI): <25, 25-30 (overweight) and >30 kg/m (obese). Outcomes after RP were compared between the groups in terms of length of stay, perioperative complications, BCR, PSM and Gleason scores.
Age, stage and preoperative prostate-specific antigen were similar between BMI categories. Operating time was prolonged in obese patients (146 vs 135 min, P = 0.01) and blood loss was greater (mean estimated blood loss 640 vs 504 mL, P = 0.02), but did not translate into higher transfusion rates. Early complication rates, PSM rates and Gleason scores were not statistically different between the groups. Significant differences in late outcomes, such as the need for adjunct procedures or BCR (hazard ratio 0.44, 95% CI 0.18-1.09), were not shown.
As surgical experience with high BMI patients has developed, RP appears to be a well tolerated procedure in contemporary series, irrespective of BMI. In particular, early outcome parameters, such as PSM and BCR rates, are similar.
肥胖被认为是前列腺癌患者根治性前列腺切除术后疾病特异性生存率降低、阳性切缘(PSM)增加和生化复发(BCR)的危险因素。本研究旨在明确肥胖与接受前列腺切除术(RP)患者手术结果的关系。
从我们的机构数据库中检索了 2004 年至 2007 年间接受 RP 的 491 名患者的病历。根据体重指数(BMI)将患者分为三组:<25、25-30(超重)和>30 kg/m(肥胖)。比较各组患者在住院时间、围手术期并发症、BCR、PSM 和 Gleason 评分方面的 RP 术后结果。
BMI 类别之间的年龄、分期和术前前列腺特异性抗原相似。肥胖患者的手术时间延长(146 分钟 vs 135 分钟,P=0.01),出血量更大(平均估计出血量 640 毫升 vs 504 毫升,P=0.02),但并未导致更高的输血率。各组之间早期并发症发生率、PSM 率和 Gleason 评分无统计学差异。没有显示晚期结果(如需要辅助治疗或 BCR 的发生率)存在显著差异(危险比 0.44,95%CI 0.18-1.09)。
随着对高 BMI 患者手术经验的发展,在当代系列中,RP 似乎是一种可以耐受的手术,与 BMI 无关。特别是,早期结果参数,如 PSM 和 BCR 率,相似。